As the world waits for a vaccine to protect against COVID-19, the disease caused by the novel coronavirus, it will need not only scientific excellence but also business continuity excellence to keep vital research and immunogenicity studies running. Vaccine development relies on many early, nonclinical studies; some of the earliest …
Patient Intelligence: designing clinical trials in the COVID-19 era
In the age of COVID-19, patients can’t wait for new vaccines and therapies to come to the market. That is why even in these challenging times, we have been focused more than ever on understanding the patient perspective on clinical trial participation. As social distancing has become the new normal, …
Labcorp delivers unmatched COVID-19 diagnostic and therapeutic applications
We’re in this together: How they are delivering unmatched acceleration of COVID-19 diagnostic and therapeutic applications Accelerating much needed COVID-19 testing, vaccines and treatment options across the world can’t be done alone. We’re in this together and ready to apply our unique combination of solutions that blend Covance and Labcorp’s …